ABSCI CORP Debt Securities Available For Sale Excluding Accrued Interest
ABSCI CORP (ABSI) had Debt Securities Available For Sale Excluding Accrued Interest of $191.68 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets
us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest · last filed 2026-08-11
- 2026-06-30: Debt Securities Available For Sale Excluding Accrued Interest $191.68M.
- 2026-03-31: Debt Securities Available For Sale Excluding Accrued Interest $122.76M.
- 2025-12-31: Debt Securities Available For Sale Excluding Accrued Interest $138.68M.
- 2025-09-30: Debt Securities Available For Sale Excluding Accrued Interest $143.19M.
| Period end | Debt Securities Available For Sale Excluding Accrued Interest |
|---|---|
| 2026-06-30 | $191.68M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $122.76M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $138.68M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $143.19M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $87.84M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $86.99M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $73.35M 10-K · filed 2026-03-24 |
| 2024-09-30 | $88.93M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $107.38M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $116.15M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $40.49M 10-K · filed 2025-03-18 |
| 2023-09-30 | $54.29M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $63.56M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $138.35M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $109.53M 10-K · filed 2024-03-21 |
| 2022-09-30 | $105.35M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $50.00M 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |